Morroniside cinnamic acid conjugate as an anti-inflammatory agent

Bioorganic and Medicinal Chemistry Letters

Volumn 20, Issue 16, 2010, Pages 4855-4857

  Takeda, Yoshinori ^a   Tanigawa, Naomi ^b   Sunghwa, Fortunatus ^c   Ninomiya, Masayuki ^a   Hagiwara, Makoto ^b   Matsushita, Kenji ^b   Koketsu, Mamoru ^a  

^a GIFU UNIVERSITY   (Japan)

^b NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^c UNIVERSITY OF DAR ES SALAAM   (Tanzania)

Author keywords

7 O Cinnamoylmorroniside; Anti inflammatory activity; Morroniside

Indexed keywords

7 O CINNAMOYLMORRONISIDE; CINNAMIC ACID DERIVATIVE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HARPAGOSIDE; IRIDOID; MORRONISIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; CINNAMIC ACID; GLYCOSIDE; PHENYLPROPIONIC ACID DERIVATIVE; PYRAN DERIVATIVE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ADHESION; CONTROLLED STUDY; DRUG ISOLATION; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN EXPRESSION; STRYCHNOS; CELL LINE; CHEMISTRY; METABOLISM; SYNTHESIS;

ANTI-INFLAMMATORY AGENTS; CELL LINE; CINNAMATES; E-SELECTIN; GLYCOSIDES; HUMANS; PHENYLPROPIONATES; PYRANS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77955421460     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2010.06.095     Document Type: Article

References (31)

1. L.A. Lasky Annu. Rev. Biochem. 64 1995 113
2. M.P. Bevilacqua, and R.M. Nelson J. Clin. Invest. 91 1993 379
3. M.P. Bevilacqua, J.S. Pober, D.L. Mendrick, R.S. Cotran, and M.A. Gimbrone Proc. Natl. Acad. Sci. U.S.A. 84 1987 9238
4. J. Eich, M. Schmidt, and G. Betti Pharm. Pharmacol. Lett. 8 1998 75
5. M.H. Jang, S. Lim, S.M. Han, H.J. Park, I. Shin, J.W. Kim, N.J. Kim, J.S. Lee, K.A. Kim, and C.J. Kim J. Pharmacol. Sci. 93 2003 367
6. J.K. Kundu, K.S. Mossanda, H.K. Na, and Y.J. Surh J. Cancer Lett. 218 2005 21
7. N. Abdelouahab, and C. Heard J. Nat. Prod. 71 2008 746
8. K. Inaba, K. Murata, S. Naruto, and H. Matsuda J. Nat. Med. 64 2010 219
9. T. Endo, and H. Taguchi Yakugaku Zasshi 93 1973 30
10. T. Yokozawa, N. Yamabe, H.Y. Kim, K.S. Kang, J.M. Hur, C.H. Park, and T. Tanaka Biol. Pharm. Bull. 31 2008 1422
11. F. Bailleul, A.M. Leveau, and M. Durand J. Nat. Prod. 44 1981 573
12. I. Calis, and O. Sticher Phytochemistry 23 1984 2539
13. J.F. Hu, C.M. Starks, R.B. Williams, S.M. Rice, V.L. Norman, K.M. Olson, G.W. Hough, M.G. Goering, M. O'Neil-Jonson, and G.R. Eldridge Helv. Chim. Acta 92 2009 273
14. H. Sakai, R. Kakuda, Y. Yaoita, and M. Kikuchi J. Nat. Med. 61 2007 226
15. W. Wang, W. Huang, L. Li, H. Ai, F. Sun, C. Liu, and Y. An Cell. Mol. Neurobiol. 28 2008 293
16. Yin, M.; Lou, F.; Cao, Q.; Han, J.; Ji, H. China Patent CN 1839869, 2006.
17. C.H. Park, N. Yamabe, J.S. Noh, K.S. Kang, T. Tanaka, and T. Yokozawa Biol. Pharm. Bull. 32 2009 1734
18. F. Sunghwa, H. Sakurai, I. Saiki, and M. Koketsu Chem. Pharm. Bull. 57 2009 112
19. F. Sunghwa, and M. Koketsu Nat. Prod. Res. 23 2009 1408
20. S.R. Jensen, and B.J. Nielsen Phytochemistry 13 1974 517
21. +.
22. +.
23. +.
24. K.C. Nicolaou, M.R. Pavia, and S.P. Seitz J. Am. Chem. Soc. 104 1982 2027
25. D.R. Williams, D.L. Brown, and J.W. Benbow J. Am. Chem. Soc. 111 1989 1923
26. J.M. Chong, and K.K. Sokoll Org. Prep. Proced. Int. 25 1993 639
27. C.H. Heathcock, and R. Ratcliffe J. Am. Chem. Soc. 93 1971 1746
28. N. Ikemoto, and S.L. Schreiber J. Am. Chem. Soc. 114 1992 2524
29. +.
30. 4 cells of HUVEC were seeded into a 96-well microtiter plate-and grown with EBM-2 overnight. Medium was replaced to DMEM before the cells were pretreated with 10 ng/ml of TNF-α. Two hours after the addition of TNF-α, the medium was removed and the cell layer was washed three times with ice-cold PBS/1% BSA and fixed with 4% paraformaldehyde phosphate buffer. After being washed with PBS five times, the cells were incubated with PBS/1% BSA for 60 min. After being washed with PBS three times, the cells were incubated with an anti-E-selectin antibody at 4 °C overnight (1:1000 in PBS/1% BSA). After being washed with PBS three times, the AP-conjugated secondary antibody (1:500 in PBS/1% BSA) was added for 120 min. After the addition of p-nitrophenyl phosphate (pNPP) solution, the enzymatic reaction was allowed to proceed for 60 min at room temperature; the optical density (OD: 405 nm) was measured using the ELISA plate reader. At least three independent experiments (each performed in triplicate) were used for the statistical interpretation of the data (means ± SEM).
31. M.C. Recio, R.M. Giner, S. Manez, and J.L. Rios Planta Med. 60 1994 232